First human test for new drug IBI3032 begins
NCT ID NCT07120425
Summary
This is a very early study to check if a new drug called IBI3032 is safe for people and to see how the body processes it. It will involve 32 healthy volunteers who will receive a single dose. The main goal is to find a safe dose and understand the drug's basic behavior in the body; it is not intended to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON Clinical Research
RECRUITINGLenexa, Kansas, 66219, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.